We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$157M
1-Year Est. Return
46.57%
This Fund
S&P 500
This Quarter
Est. Return
-14.31%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
–
AUM
$127M
AUM Growth
-$27.3M
(-18%)
Cap. Flow
-$1.6M
Cap. Flow
% of AUM
-1.26%
Top 10 Holdings %
Top 10 Hldgs %
43.52%
Holding
112
New
3
Increased
9
Reduced
48
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EGIO
Edgio, Inc. Common Stock
EGIO
|
+$647K |
| 2 |
Airbnb
ABNB
|
+$455K |
| 3 |
Dorchester Minerals
DMLP
|
+$384K |
| 4 |
IBM
IBM
|
+$361K |
| 5 |
Vermilion Energy
VET
|
+$283K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$540K |
| 2 |
CYBE
Cyberoptics Corp
CYBE
|
+$427K |
| 3 |
OptimizeRx
OPRX
|
+$399K |
| 4 |
Intellicheck
IDN
|
+$371K |
| 5 |
TWOU
2U Inc
TWOU
|
+$367K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.7% |
| 2 | Technology | 22.57% |
| 3 | Energy | 12.98% |
| 4 | Financials | 10.58% |
| 5 | Industrials | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
1
Novo Nordisk
NVO
$208B
| $19.1M | 15.08% |
343,300
| – | – |
|
|
2
Microsoft
MSFT
$3.62T
| $8.38M | 6.61% |
32,641
-1,990
| -6% | -$540K |
|
3
Amazon
AMZN
$3.06T
| $5.75M | 4.53% |
54,100
+100
| +0.2% | +$12.5K |
|
4
Moody's
MCO
$83.7B
| $4.01M | 3.16% |
14,750
-350
| -2% | -$105K |
|
5
Thomson Reuters
TRI
$44.4B
| $3.41M | 2.69% |
31,062
| – | – |
|
6
Alphabet (Google) Class C
GOOG
$4.56T
| $3.39M | 2.68% |
31,020
| – | – |
|
|
7
Alphabet (Google) Class A
GOOGL
$4.57T
| $3.18M | 2.51% |
29,200
-700
| -2% | -$82.4K |
|
|
VRN
8
DELISTED
Veren
VRN
| $2.77M | 2.19% |
391,155
+31,705
| +9% | +$249K |
|
9
Axcelis
ACLS
$4.03B
| $2.63M | 2.07% |
47,925
-225
| -0.5% | -$13K |
|
10
Photronics
PLAB
$1.85B
| $2.53M | 1.99% |
129,750
-9,150
| -7% | -$160K |
|
11
Azenta
AZTA
$1.38B
| $2.39M | 1.88% |
33,115
-1,075
| -3% | -$80.3K |
|
|
12
Vermilion Energy
VET
$1.76B
| $2.34M | 1.84% |
123,130
+13,580
| +12% | +$283K |
|
13
Blackstone
BX
$108B
| $2.26M | 1.78% |
24,755
-500
| -2% | -$54K |
|
14
Cohu
COHU
$2.31B
| $2.11M | 1.66% |
75,935
-200
| -0.3% | -$5.52K |
|
15
USA Compression Partners
USAC
$3.73B
| $1.85M | 1.46% |
110,625
+6,800
| +7% | +$122K |
|
16
Targa Resources
TRGP
$56.8B
| $1.84M | 1.45% |
30,875
-50
| -0.2% | -$3.59K |
|
17
Nuveen New York Municipal Value Fund
NNY
$155M
| $1.82M | 1.43% |
213,727
| – | – |
|
18
Sony
SONY
$133B
| $1.72M | 1.35% |
105,000
| – | – |
|
19
Popular Inc
BPOP
$11.1B
| $1.65M | 1.3% |
21,425
-50
| -0.2% | -$3.98K |
|
20
Apple
AAPL
$4.43T
| $1.62M | 1.28% |
11,861
-1,400
| -11% | -$212K |
|
21
Fidelity National Financial
FNF
$13.9B
| $1.59M | 1.25% |
44,688
-114
| -0.3% | -$4.46K |
|
22
Verizon
VZ
$197B
| $1.54M | 1.21% |
30,349
-400
| -1% | -$20.2K |
|
23
Automatic Data Processing
ADP
$107B
| $1.53M | 1.21% |
7,300
| – | – |
|
|
CYBE
24
DELISTED
Cyberoptics Corp
CYBE
| $1.34M | 1.06% |
38,480
-10,435
| -21% | -$427K |
|
25
State Street SPDR S&P 500 ETF Trust
SPY
$806B
| $1.18M | 0.93% |
3,135
| – | – |
|
Similar funds
IWM
EP
AC
SF
LAM
HAM
HEM
CF
Penbrook Management's Q2 2022 Portfolio in Review
As of Q2 2022, Penbrook Management held 112 positions worth $127M, down 18% from $154M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Penbrook Management's Q2 2022 filing shows 3 new, 9 increased, 48 reduced and 6 closed positions. Its largest new stake was Edgio, Inc. Common Stock: 4,494 shares worth $415K. The largest sale was Microsoft, an estimated $540K.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Energy.
- Penbrook Management's largest Q2 2022 buy was Edgio, Inc. Common Stock: 4,494 shares worth $415K.
- Penbrook Management added most to IBM in Q2 2022, an estimated $361K increase.
- Penbrook Management's biggest Q2 2022 reduction was Microsoft, cutting an estimated $540K.
- Penbrook Management fully exited OptimizeRx in Q2 2022, selling an estimated $399K.
- Penbrook Management's ten largest holdings make up 44% of its $127M portfolio in Q2 2022.
- Penbrook Management opened 3 new positions and closed 6 in Q2 2022.
- Penbrook Management's portfolio value fell 18% quarter-over-quarter to $127M.
Based on Penbrook Management's 13F filing for Q2 2022, filed 29 Jul 2022.